REGENXBIO, Inc. (RGNX)
8.03
-0.06
(-0.74%)
USD |
NASDAQ |
Oct 09, 15:23
REGENXBIO 30-Day Average Daily Volume : 1.404M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.404M |
| October 07, 2026 | 1.367M |
| October 06, 2026 | 1.392M |
| October 05, 2026 | 1.535M |
| October 02, 2026 | 1.490M |
| October 01, 2026 | 1.487M |
| September 30, 2026 | 1.468M |
| September 29, 2026 | 1.430M |
| September 28, 2026 | 1.394M |
| September 25, 2026 | 1.377M |
| September 24, 2026 | 1.361M |
| September 23, 2026 | 1.340M |
| September 22, 2026 | 1.332M |
| September 21, 2026 | 1.325M |
| September 18, 2026 | 1.334M |
| September 17, 2026 | 1.280M |
| September 16, 2026 | 1.271M |
| September 15, 2026 | 1.262M |
| September 14, 2026 | 1.242M |
| September 11, 2026 | 1.251M |
| September 10, 2026 | 1.258M |
| September 09, 2026 | 1.255M |
| September 08, 2026 | 1.254M |
| September 04, 2026 | 1.263M |
| September 03, 2026 | 1.259M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.277M |
| September 01, 2026 | 1.287M |
| August 31, 2026 | 1.326M |
| August 28, 2026 | 1.349M |
| August 27, 2026 | 1.541M |
| August 26, 2026 | 1.577M |
| August 25, 2026 | 1.578M |
| August 24, 2026 | 1.572M |
| August 21, 2026 | 1.464M |
| August 20, 2026 | 1.542M |
| August 19, 2026 | 1.576M |
| August 18, 2026 | 1.617M |
| August 17, 2026 | 1.689M |
| August 14, 2026 | 1.759M |
| August 13, 2026 | 1.842M |
| August 12, 2026 | 1.967M |
| August 11, 2026 | 1.991M |
| August 10, 2026 | 2.047M |
| August 07, 2026 | 2.159M |
| August 06, 2026 | 2.165M |
| August 05, 2026 | 2.185M |
| August 04, 2026 | 2.233M |
| August 03, 2026 | 2.504M |
| July 31, 2026 | 2.584M |
| July 30, 2026 | 2.711M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| AbbVie, Inc. | 4.415M |
| United Therapeutics Corp. | 895537.1 |
| Ardelyx, Inc. | 4.292M |
| Biomea Fusion, Inc. | 1.959M |
| RenovoRx, Inc. | 1.170M |